Who owns ORCHARD THERAPEUTICS PLC?
- CUSIP Number: 68570p200
Tip: Access positions for across all investors
Analyze quarterly positions in Orchard Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Orchard Therapeutics stock
Who bought or sold ORCHARD THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 869k | $14M | 0% | Dec 2023 |
|
| Vident Advisory | 11k | $185k | 100% | Dec 2023 |
|
Who sold out of Orchard Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Blue Owl Capital Holdings | Dec 2023 | 1.6M | $2.6M |
| Beryl Capital Management | Dec 2023 | 1.6M | $26M |
| LMR Partners | Dec 2023 | 332k | $5.5M |
| Tudor Investment Corporation | Dec 2023 | 300k | $4.9M |
| Platinum Investment Mangement | Sep 2023 | 249k | $1.9M |
| Millennium Management | Dec 2023 | 239k | $3.9M |
| Goldman Sachs Group | Dec 2023 | 138k | $2.3M |
| Acadian Asset Management | Sep 2023 | 121k | $936k |
| CSS | Dec 2023 | 64k | $1.1M |
| ADAR1 Capital Management | Dec 2023 | 64k | $1.0M |
| Bck Capital Management | Dec 2023 | 44k | $718k |
| Jane Street | Dec 2023 | 42k | $696k |
| FMR | Sep 2023 | 41k | $320k |
| Susquehanna International | Sep 2023 | 30k | $232k |
| Jpmorgan Chase & Co | Dec 2023 | 27k | $447k |
| Hrt Financial | Dec 2023 | 25k | $406k |
| PenderFund Capital Management | Dec 2023 | 24k | $514k |
| Gts Securities | Dec 2023 | 15k | $247k |
| FNY Investment Advisers | Dec 2023 | 15k | $246k |
| Forefront Analytics | Sep 2023 | 14k | $110k |
| Morgan Stanley | Sep 2023 | 12k | $93k |